Groeben Harald, Nottebaum Bente J, Feldheiser Aarne, Buch Steffen, Alesina Piero F, Walz Martin K
Department of Anaesthesia, Critical Care Medicine and Pain Therapy, Essen, Germany.
Department of Surgery and Center of Minimally Invasive Surgery, Kliniken Essen-Mitte, Essen, Germany.
BJA Open. 2023 Dec 6;8:100240. doi: 10.1016/j.bjao.2023.100240. eCollection 2023 Dec.
Guidelines for the treatment of catecholamine-producing tumours strictly recommend starting ß-receptor blocking medication only after α-receptor blockade has been established. This recommendation is supported only by non-surgical case reports. However, in clinical practice ß-receptor blockade is often started before the diagnosis of a phaeochromocytoma is made. As we routinely treat patients with catecholamine-producing tumours without α-receptor blockade, our aim was to evaluate haemodynamic changes in such patients with and without ß-receptor blockade.
Perioperative blood pressure was assessed prospectively for all patients. The primary outcome was the highest pre-, intra-, and postoperative systolic blood pressure in patients with or without a ß-receptor blockade. Secondary outcomes were the incidence of intraoperative systolic blood pressure peaks >250 mm Hg and hypotensive episodes. Subsequently, a propensity score matching (PSM) analysis was performed.
Out of 584 phaeochromocytoma and paraganglioma resections, 383 operations were performed without α-receptor blockade (including 84 with ß-receptor blockade). Before operation and intraoperatively, patients with ß-receptor blockade presented with higher systolic blood pressure (155 [25] and 207 [62] mm Hg) than patients without ß-receptor blockade (147 [24] and 183 [52] mm Hg; =0.006 and =0.001, respectively). Intraoperatively, patients with ß-receptor blockade demonstrated a higher incidence of hypotensive episodes (25% without 41% with ß-blockade; <0.001). After propensity score matching no difference between the groups could be confirmed.
Overall, patients with isolated ß-receptor blockade developed higher blood pressure before operation and intraoperatively. After propensity score matching a difference could no longer be detected. Overall, ß-receptor blockade seems to be more a sign for severe disease than a risk factor for haemodynamic instability.
嗜铬细胞瘤的治疗指南严格建议,仅在确立α受体阻滞治疗后,才开始使用β受体阻滞剂。这一建议仅得到非手术病例报告的支持。然而,在临床实践中,β受体阻滞剂常常在嗜铬细胞瘤确诊之前就开始使用。由于我们常规治疗嗜铬细胞瘤患者时未进行α受体阻滞,我们的目的是评估此类患者在使用和未使用β受体阻滞剂情况下的血流动力学变化。
对所有患者进行围手术期血压的前瞻性评估。主要结局指标是使用或未使用β受体阻滞剂患者术前、术中和术后的最高收缩压。次要结局指标是术中收缩压峰值>250 mmHg和低血压发作的发生率。随后进行倾向评分匹配(PSM)分析。
在584例嗜铬细胞瘤和副神经节瘤切除术中,383例手术未进行α受体阻滞(包括84例使用β受体阻滞剂)。术前和术中,使用β受体阻滞剂的患者收缩压(分别为155 [25]和207 [62] mmHg)高于未使用β受体阻滞剂的患者(分别为147 [24]和183 [52] mmHg;P分别为0.006和0.001)。术中,使用β受体阻滞剂的患者低血压发作发生率更高(未使用β受体阻滞剂为25%,使用β受体阻滞剂为41%;P<0.001)。倾向评分匹配后,两组之间未发现差异。
总体而言,单纯使用β受体阻滞剂的患者术前和术中血压较高。倾向评分匹配后,差异不再明显。总体而言,β受体阻滞剂似乎更多是重症疾病的标志,而非血流动力学不稳定的危险因素。